Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) Director Saira Ramasastry sold 5,000 shares of Mirum Pharmaceuticals stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $25.68, for a total value of $128,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]
Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.